{"pmid":32339299,"title":"Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?","text":["Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?","Allergy","Gursel, Mayda","Gursel, Ihsan","32339299"],"journal":"Allergy","authors":["Gursel, Mayda","Gursel, Ihsan"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32339299","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1111/all.14345","topics":["Treatment","Mechanism"],"weight":1,"_version_":1665264685603094529,"score":8.574329,"similar":[{"pmid":32305501,"pmcid":"PMC7162764","title":"The Potential Role of Th17 Immune Responses in Coronavirus Immunopathology and Vaccine-induced Immune Enhancement.","text":["The Potential Role of Th17 Immune Responses in Coronavirus Immunopathology and Vaccine-induced Immune Enhancement.","Increasing evidence points to host Th17 inflammatory responses as contributing to the severe lung pathology and mortality of lower respiratory tract infections from coronaviruses. This includes host inflammatory and cytokine responses to COVID-19 caused by the SARS-2 coronavirus (SARS CoV2). From studies conducted in laboratory animals, there are additional concerns about immune enhancement and the role of potential host immunopathology resulting from experimental human COVID-19 vaccines. Here we summarize evidence suggesting there may be partial overlap between the underlying immunopathologic processes linked to both coronavirus infection and vaccination, and a role for Th17 in immune enhancement and eosinophilic pulmonary immunopathology. Such findings help explain the link between viral-vectored coronavirus vaccines and immune enhancement and its reduction through alum adjuvants. Additional research may also clarify links between COVID-19 pulmonary immunopathology and heart disease.","Microbes Infect","Hotez, Peter J","Bottazzi, Maria Elena","Corry, David B","32305501"],"abstract":["Increasing evidence points to host Th17 inflammatory responses as contributing to the severe lung pathology and mortality of lower respiratory tract infections from coronaviruses. This includes host inflammatory and cytokine responses to COVID-19 caused by the SARS-2 coronavirus (SARS CoV2). From studies conducted in laboratory animals, there are additional concerns about immune enhancement and the role of potential host immunopathology resulting from experimental human COVID-19 vaccines. Here we summarize evidence suggesting there may be partial overlap between the underlying immunopathologic processes linked to both coronavirus infection and vaccination, and a role for Th17 in immune enhancement and eosinophilic pulmonary immunopathology. Such findings help explain the link between viral-vectored coronavirus vaccines and immune enhancement and its reduction through alum adjuvants. Additional research may also clarify links between COVID-19 pulmonary immunopathology and heart disease."],"journal":"Microbes Infect","authors":["Hotez, Peter J","Bottazzi, Maria Elena","Corry, David B"],"date":"2020-04-20T11:00:00Z","year":2020,"_id":"32305501","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.micinf.2020.04.005","source":"PubMed","topics":["Treatment","Mechanism"],"weight":1,"_version_":1664641855712657408,"score":51.364944},{"pmid":32330314,"title":"Is BCG vaccination effecting the spread and severity of COVID-19?","text":["Is BCG vaccination effecting the spread and severity of COVID-19?","Allergy","Ozdemir, Cevdet","Kucuksezer, Umut C","Tamay, Zeynep Ulker","32330314"],"journal":"Allergy","authors":["Ozdemir, Cevdet","Kucuksezer, Umut C","Tamay, Zeynep Ulker"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330314","week":"202017|Apr 20 - Apr 26","doi":"10.1111/all.14344","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1664996914776506368,"score":45.3707},{"pmid":32295694,"title":"COVID-19 vaccination clinical trials should consider multiple doses of BCG.","text":["COVID-19 vaccination clinical trials should consider multiple doses of BCG.","Pharmazie","Ayoub, B M","32295694"],"journal":"Pharmazie","authors":["Ayoub, B M"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32295694","week":"202016|Apr 13 - Apr 19","doi":"10.1691/ph.2020.0444","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1664641388293128192,"score":41.454712}]}